triaziquone has been researched along with Sarcoma 180 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Faufmann, M; MAttern, J; Volm, M; Wayss, K | 1 |
Lindner, C; Volm, M | 1 |
2 other study(ies) available for triaziquone and Sarcoma 180
Article | Year |
---|---|
Sensitivity tests of tumors to cytostatic agents. I. Comparative investigations on transplanted tumors in vivo and in vitro.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cell Division; Cricetinae; Dactinomycin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Fluorouracil; In Vitro Techniques; Melanoma; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Plasmacytoma; Procarbazine; Rats; Rats, Inbred ACI; Sarcoma 180; Thymidine; Triaziquone; Uridine | 1975 |
Detection of induced resistance in short-term-tests. Adriamycin-resistant sarcoma 180.
Topics: Animals; Cell Line; Deoxyuridine; Doxorubicin; Drug Resistance; Mice; Sarcoma 180; Thymidine; Time Factors; Triaziquone; Uridine | 1978 |